Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34387
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPark, Seunga-
dc.contributor.authorKalfas, Stefanie-
dc.contributor.authorFazio, Timothy N-
dc.contributor.authorSerpa Neto, Ary-
dc.contributor.authorMacisaac, Christopher-
dc.contributor.authorRead, David J-
dc.contributor.authorDrummond, Katharine J-
dc.contributor.authorBellomo, Rinaldo-
dc.date2023-
dc.date.accessioned2023-12-13T05:24:37Z-
dc.date.available2023-12-13T05:24:37Z-
dc.date.issued2021-12-06-
dc.identifier.citationCritical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine 2021-12-06; 23(4)en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/34387-
dc.description.abstractObjective: Traumatic brain injury (TBI) patients with prolonged intensive care unit (ICU) stay are at risk of secondary intracranial haemorrhage (ICH) and venous thromboembolism (VTE). We aimed to study VTE prophylaxis, secondary ICH, and VTE prevalence and outcomes in this population. Design: Retrospective observational study. Setting: Level 1 trauma centre ICU. Patients: One hundred TBI patients receiving prolonged ICU treatment (≥ 7 days). Interventions: We collected data from medical records, pathology and radiology systems, and hospital and ICU admission databases. We analysed patient characteristics, interventions, episodes and types of secondary ICH and VTE, and timing and dosage of VTE prophylaxis. Results: Data from the 100 patients in our study showed that early use of compression stockings and pneumatic calf compression was common (75% and 91% in the first 3 days, respectively). VTE chemoprophylaxis, however, was only used in 14% of patients by Day 3 and > 50% by Day 10. We observed VTE in 12 patients (10 as pulmonary embolism), essentially all after Day 6. Radiologically confirmed secondary ICH occurred in 43% of patients despite normal coagulation. However, 72% of ICH events (42/58) were radiologically mild, and the median time of onset of ICH was Day 1, when only 3% of patients were on chemical prophylaxis. Moreover, 82% of secondary ICH events (48/58) occurred in the first 3 days, with no severe ICH thereafter. Conclusions: In TBI patients receiving prolonged ICU treatment, early chemical VTE prophylaxis was uncommon. Early secondary ICH was common and mostly radiologically mild, whereas later secondary ICH was essentially absent. In contrast, early VTE was essentially absent, whereas later VTE was relatively common. Earlier chemical VTE prophylaxis and/or ultrasound screening in this population appears logical.en_US
dc.language.isoeng-
dc.titleVenous thromboembolism prophylaxis and related outcomes in patients with traumatic brain injury and prolonged intensive care unit stay.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleCritical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicineen_US
dc.identifier.affiliationFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationHealth Intelligence Unit, Royal Melbourne Hospital, Melbourne, VIC, Australia.;Melbourne Medical School, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.;Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, VIC, Australia.;Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.en_US
dc.identifier.affiliationDepartment of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia.;Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationTrauma Unit, Royal Melbourne Hospital, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationDepartment of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia.;Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.;Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, VIC, Australia.;Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationIntensive Careen_US
dc.identifier.doi10.51893/2021.4.OA1en_US
dc.type.contentTexten_US
dc.identifier.pubmedid38046690-
dc.description.volume23-
dc.description.issue4-
dc.description.startpage364-
dc.description.endpage373-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on Nov 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.